ClinicalTrials.govpublic full text
Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure
atrial fibrillation, atrial appendage, hemorrhage, left atrial appendage closure, rivaroxaban, dual antiplatelet therapy, anticoagulation, stroke prevention, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 879919
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.